Merck KGaA (MRKd)
FRA • Healthcare
July 14, 2026 at 15:30 UTC
About Merck KGaA
Merck KGaA trades on XETRA under MRK.DE and operates as a healthcare company with prescription medicines at its core, alongside laboratory and industrial supplies and electronic materials. In FY2025, it generated EUR 21.1 billion in revenue. The company is a subsidiary of E. Merck KG.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Merck KGaA's Technical Indicators Summary
MRK.DE shows a balanced technical picture: ADX indicates a modestly firm trend while short-term momentum readings are muted and the 10–20 period averages sit above the current price, signaling near-term pressure even as the 50/100/200-day averages remain well below and imply longer-term support. Volume-based OBV and VWAP are mildly constructive, and volatility is moderate. Taken together, the chart reflects mixed short-term weakness against underlying longer-term support, producing a neutral stance. Technical takeaway: Neutral.
| Indicator | Value |
|---|---|
RSI (14) | 52.72 |
Stochastic %K (14, 3, 3) | 32.78 |
CCI (20) | -26.59 |
WPR (14) | -79.57 |
Momentum (10) | -7.35 |
MFI | 59.02 |
MACD Level (12, 26) | 2.19 |
Bollinger Bands | $130.44 - $150.89 |
ATR (14) | $3.12 (2.24%) |
ADX (14) | 27.70 |
OBV | 220,777 |
VWAP | $138.25 |
Classic Pivot Point | $139.25 |
Fibonacci Pivot Point | $139.25 |
Simple Moving Averages | $121.16 - $142.00(5 indicators) |
Exponential Moving Averages | $122.45 - $140.84(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
MRKd finished -0.89% below yesterday's close of 139.85. End-of-day turnover for MRKd stayed minimal, stuck at 0.27× normal activity. MRKd to sell Curiosis's cell imaging system under its own brand.
Trading Volume
Below avg (244.7K)
65K
vs S&P 500 Today
Underperforming Market
-1.15%
52-Week Position
Upper range
79%
Updated: July 14, 2026 at 15:10 UTC
Quote Summary
MRKd Headlines
Merck KGaA to buy Bio-Techne for $11.3 billion
June 25, 2026
AI Stock Bubble Concerns Trigger Broad Market Sell-Off
November 18, 2025